0001209191-20-027496.txt : 20200506 0001209191-20-027496.hdr.sgml : 20200506 20200506164343 ACCESSION NUMBER: 0001209191-20-027496 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200504 FILED AS OF DATE: 20200506 DATE AS OF CHANGE: 20200506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sachdev Amit CENTRAL INDEX KEY: 0001406338 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 20853244 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-04 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001406338 Sachdev Amit C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Chief Patient Officer Common Stock 2020-05-04 4 M 0 32500 109.14 A 67603 D Common Stock 2020-05-04 4 M 0 9310 131.89 A 76913 D Common Stock 2020-05-04 4 M 0 1942 86.52 A 78855 D Common Stock 2020-05-04 4 S 0 1400 258.59 D 77455 D Common Stock 2020-05-04 4 S 0 6223 259.63 D 71232 D Common Stock 2020-05-04 4 S 0 8383 260.48 D 62849 D Common Stock 2020-05-04 4 S 0 4395 261.68 D 58454 D Common Stock 2020-05-04 4 S 0 9447 262.69 D 49007 D Common Stock 2020-05-04 4 S 0 964 263.58 D 48043 D Common Stock 2020-05-04 4 S 0 12940 264.92 D 35103 D Common Stock 2020-05-05 4 M 0 13356 131.89 A 48459 D Common Stock 2020-05-05 4 S 0 100 265.72 D 48359 D Common Stock 2020-05-05 4 S 0 300 267.34 D 48059 D Common Stock 2020-05-05 4 S 0 700 269.08 D 47359 D Common Stock 2020-05-05 4 S 0 11553 270.01 D 35806 D Common Stock 2020-05-05 4 S 0 100 271.09 D 35706 D Common Stock 2020-05-05 4 S 0 403 272.58 D 35303 D Common Stock 2020-05-05 4 S 0 200 273.59 D 35103 D Common Stock 882 I 401(k) Common Stock 14002 I GRAT Stock Option (Right to Buy) 109.14 2020-05-04 4 M 0 32500 0.00 D 2025-02-02 Common Stock 32500 0 D Stock Option (Right to Buy) 131.89 2020-05-04 4 M 0 9310 0.00 D 2025-07-20 Common Stock 9310 24690 D Stock Option (Right to Buy) 86.52 2020-05-04 4 M 0 1942 0.00 D 2027-02-02 Common Stock 1942 5825 D Stock Option (Right to Buy) 131.89 2020-05-05 4 M 0 13356 0.00 D 2025-07-20 Common Stock 13356 11334 D Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $258.59 (range $258.00 to $258.97). Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $259.63 (range $259.03 to $260.02). Open market sales reported on this line occurred at a weighted average price of $260.48 (range $260.05 to $261.04). Open market sales reported on this line occurred at a weighted average price of $261.68 (range $261.14 to $262.13). Open market sales reported on this line occurred at a weighted average price of $262.69 (range $262.14 to $263.11). Open market sales reported on this line occurred at a weighted average price of $263.58 (range $263.17 to $264.02). Open market sales reported on this line occurred at a weighted average price of $264.92 (range $264.29 to $265.00). Open market sales reported on this line occurred at a weighted average price of $267.34 (range $267.11 to $267.67). Open market sales reported on this line occurred at a weighted average price of $269.08 (range $268.76 to $269.53). Open market sales reported on this line occurred at a weighted average price of $270.01 (range $269.98 to $270.87). Open market sales reported on this line occurred at a weighted average price of $272.58 (range $272.35 to $272.83). Open market sales reported on this line occurred at a weighted average price of $273.59 (range $273.50 to $273.67). Fully vested. The option vests in 16 quarterly installments from 02/03/2017. /s/ Sabrina Yohai, Attorney-in-Fact 2020-05-06